Literature DB >> 23754135

Commentary on special issue: CNS diseases and the immune system.

Bert A 't Hart1, Wilfred F den Dunnen.   

Abstract

In an increasing number of central nervous system (CNS) diseases a pathogenic contribution of the immune system is proposed. However, the exact underlying mechanisms are often poorly understood. The collection of articles in this special issue presents a state-of-the-art review of adaptive and innate immune mechanisms and their main players in number CNS disorders. The aim of these articles is to stimulate discussion on the question whether the immune system may be a feasible target of therapy for diseases where currently no effective treatment exists.

Entities:  

Mesh:

Year:  2013        PMID: 23754135     DOI: 10.1007/s11481-013-9486-0

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  8 in total

1.  The marmoset monkey: a multi-purpose preclinical and translational model of human biology and disease.

Authors:  Bert A 't Hart; David H Abbott; Katsuki Nakamura; Eberhard Fuchs
Journal:  Drug Discov Today       Date:  2012-06-21       Impact factor: 7.851

Review 2.  Environmental risk factors for multiple sclerosis. Part I: the role of infection.

Authors:  Alberto Ascherio; Kassandra L Munger
Journal:  Ann Neurol       Date:  2007-04       Impact factor: 10.422

Review 3.  Epstein-barr virus: environmental trigger of multiple sclerosis?

Authors:  Jan D Lünemann; Thomas Kamradt; Roland Martin; Christian Münz
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

Review 4.  The primary lesion theory of autoimmunity: a speculative hypothesis.

Authors:  T J Wilkin
Journal:  Autoimmunity       Date:  1990       Impact factor: 2.815

5.  Combinatorial antibody library from multiple sclerosis patients reveals antibodies that cross-react with myelin basic protein and EBV antigen.

Authors:  Alexander G Gabibov; Alexey A Belogurov; Yakov A Lomakin; Maria Yu Zakharova; Marat E Avakyan; Viktorya V Dubrovskaya; Ivan V Smirnov; Alexis S Ivanov; Andrey A Molnar; Vladimir E Gurtsevitch; Sergey V Diduk; Ksenia V Smirnova; Bérangère Avalle; Svetlana N Sharanova; Alfonso Tramontano; Alain Friboulet; Alexey N Boyko; Natalia A Ponomarenko; Nina V Tikunova
Journal:  FASEB J       Date:  2011-08-22       Impact factor: 5.191

6.  A functional and structural basis for TCR cross-reactivity in multiple sclerosis.

Authors:  Heather L E Lang; Helle Jacobsen; Shinji Ikemizu; Christina Andersson; Karl Harlos; Lars Madsen; Peter Hjorth; Leif Sondergaard; Arne Svejgaard; Kai Wucherpfennig; David I Stuart; John I Bell; E Yvonne Jones; Lars Fugger
Journal:  Nat Immunol       Date:  2002-09-03       Impact factor: 25.606

Review 7.  Multiple sclerosis - a response-to-damage model.

Authors:  Bert A 't Hart; Rogier Q Hintzen; Jon D Laman
Journal:  Trends Mol Med       Date:  2009-05-18       Impact factor: 11.951

8.  The Primate EAE Model Points at EBV-Infected B Cells as a Preferential Therapy Target in Multiple Sclerosis.

Authors:  Bert A 't Hart; S Anwar Jagessar; Krista Haanstra; Ernst Verschoor; Jon D Laman; Yolanda S Kap
Journal:  Front Immunol       Date:  2013-06-13       Impact factor: 7.561

  8 in total
  2 in total

1.  Immunohistochemical Assessment of Inflammation and Regeneration in Morphine-Dependent Rat Brain.

Authors:  Maryam Iranpour; Sadaf Torkzadeh-Tabrizi; Zeinab Khatoon-Asadi; Reza Malekpour-Afshar
Journal:  Addict Health       Date:  2018-07

Review 2.  Sirtuins promote brain homeostasis, preventing Alzheimer's disease through targeting neuroinflammation.

Authors:  Mateusz Watroba; Dariusz Szukiewicz
Journal:  Front Physiol       Date:  2022-08-15       Impact factor: 4.755

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.